On March 24 world-renowned pharmaceutical company Eli Lilly & Co. and HISUN jointly announced that the technological transfer for the Caproemycin production line provided by Eli Lilly free of charge, had passed the latter's certification, thus signifying that Chinese pharmaceutical enterprise now possessed as Eli Lilly did, production capability for Caproemycin. At the same time HISUN obtained the production conditions for providing medicine to global TB patients.
Related News
- Mr. Li Wei, deputy director of state asset regulatory commission of the State Council, came to Hisun
- The First Batch of Oral Solid Preparations of Hisun Pharmaceuticals Export to European Market
- The company has held 2006 shareholders' meeting
- Conch Profile have participated in 2007 annual meeting of plastic doors and windows trade
Photos
More>>
trade
- Neusoft Recognized Again on Global Services 100 List 2006 and also Ranked No. 1
- Intel Capital Signs US$40m Investment Agreement with Neusoft
- Neusoft Listed in The 2007 Global Services 100
- Dr.Liu Jiren Awarded Asia Innovator of the Year at the 6th CNBC Asia Business
- Neusoft CEO Attended the 2010 Summer Davos and Highlighted the New Challenges
market
- Neusoft CEO Dr. Liu Jiren Named Country Winner of Ernst and Young Entrepreneur
- Kaisa Group received 2010 Listed Real Estate Company of the Highest Investment
- Kaisa Group announces interim results for 2010
- Kaisa Group among TOP10 brands of South China real estate companies 6 years in a
- Kaisa Group earned PRC best employer title for 2010
finance
- Campus recruitment for 2011 graduates started with Shenzhen University
- Kaisa Group named among Most Valuable PRC Listed Blue-chip Real Estate Companies
- Kaisa Group ranks 5th among TOP 10 China-Affiliated HK-Listed Companies of
- Insigma being awarded the Grand Prize for Y2009 International Service Outsourcin
- Insigma Continues to Hold 2nd Place in China s Software Outsourcing Industry in